Simone Tammaro1, Francesco Di Fiore2, Felice Crocetto3, Celeste Manfredi1,*, Claudia Collà Ruvolo3, Gianluigi Califano3, Biagio Barone4, Davide Arcaniolo1, Lorenzo Spirito1, Francesco Paolo Calace2, Pasquale Reccia2, Ferdinando Fusco1, Marco De Sio1, Raffaele Balsamo2
Canadian Journal of Urology, Vol.33, No.2, pp. 249-259, 2026, DOI:10.32604/cju.2025.072617
- 20 April 2026
Abstract Background: Thulium laser vaporization of the prostate (ThuVAP) is an established treatment for benign prostatic obstruction, but its impact on urodynamic parameters remains poorly defined. This study aimed to quantify the de-obstructive efficacy of ThuVAP through pre- and postoperative urodynamic comparisons and to assess the relationship between urodynamic improvement and symptom relief. Methods: In a prospective single-center cohort (June 2022–June 2024), men with urodynamically confirmed obstruction underwent standardized ThuVAP with a 200-W thulium:YAG system. Baseline and 6-month invasive urodynamics and 12-month clinical follow-up were performed. The primary endpoint was the change in the bladder outlet… More >